High materiality7/10
10x Genomics price target raised to $50 from $32 at Canaccord
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Canaccord Genuity raises TXG target to $50; current price is $41.77.
- Canaccord Genuity raises TXG target 50; price 41.77
Key facts
- 01
Target: $50
- 02
Posted price: $41.77
- 03
Analyst firm: Canaccord Genuity
- 04
Analyst: Kyle Mikson
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.